Expression levels of cyclooxygenase-2, tumor necrosis factor-α and inducible NO synthase in placental tissue of normal and preeclamptic pregnancies

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 25, Issue 6, 2012, Pages 826-830

  Goksu Erol, Azize Yasemin ^a,b   Nazli, Mumtaz ^c   Elis Yildiz, Sevda ^c  

^a SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b AFYON KOCATEPE UNIVERSITY   (Turkey)

^c KAFKAS UNIVERSITY   (Turkey)

Author keywords

Cyclooxygenase 2; Immunohistochemistry; Inducible NO synthase; Placenta; Preeclampsia; Tumor necrosis factor

Indexed keywords

CYCLOOXYGENASE 2; INDUCIBLE NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PATHOGENESIS; PLACENTA; PREECLAMPSIA; PREGNANT WOMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNCYTIOTROPHOBLAST;

ADULT; CASE-CONTROL STUDIES; CYCLOOXYGENASE 2; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; NITRIC OXIDE SYNTHASE TYPE II; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84861050065     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2011.595853     Document Type: Article

References (46)

1. Dekker GA, van Geijn HP. Endothelial dysfunction in preeclampsia. I: Primary prevention; therapeutic perspectives. J Perinat Med 1996;24:119-139.
2. Brosens I, Robertson WB, Dixon HG. The physiological response of the vessels of the placental bed to normal pregnancy. J Pathol Bacteriol 1967;93:569-579.
3. Pijnenborg R, Bland JM, Robertson WB, Brosens I. Uteroplacental arterial changes related to interstitial trophoblast migration in early human pregnancy. Placenta 1983;4:397-413.
4. Nasiell J, Nisell H, Blanck A, Lunell NO, Faxen M. Placental expression of endothelial constitutive nitric oxide synthase mRNA in pregnancy complicated by preeclampsia. Acta Obstet Gynecol Scand 1998;77:492-496.
5. Papageorghiou AT, Yu CK, Bindra R, Pandis G, Nicolaides KH; Fetal Medicine Foundation Second Trimester Screening Group. Multicenter screening for pre-eclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks of gestation. Ultrasound Obstet Gynecol 2001;18:441-449.
6. Papageorghiou AT, Yu CK, Cicero S, Bower S, Nicolaides KH. Secondtrimester uterine artery Doppler screening in unselected populations: A review. J Matern Fetal Neonatal Med 2002;12:78-88.
7. Di Paolo S, Volpe P, Grandaliano G, Stallone G, Schena A, Greco P, Resta L, et al. Increased placental expression of tissue factor is associated with abnormal uterine and umbilical Doppler waveforms in severe preeclampsia with fetal growth restriction. J Nephrol 2003;16:650-657.
8. Pijnenborg R, Anthony J, Davey DA, Rees A, Tiltman A, Vercruysse L, van Assche A. Placental bed spiral arteries in the hypertensive disorders of pregnancy. Br J Obstet Gynaecol 1991;98:648-655.
9. Myatt L, Miodovnik M. Prediction of preeclampsia. Semin Perinatol 1999;23:45-57.
10. Ylikorkala O, Viinikka L. The role of prostaglandins in obstetrical disorders. Baillieres Clin Obstet Gynaecol 1992;6:809-827.
11. Marshall PJ, Kulmacz RJ, Lands WE. Constraints on prostaglandin biosynthesis in tissues. J Biol Chem 1987;262:3510-3517.
12. Appleby SB, Ristimaki A, Neilson K, Narko K, Hla T. Structure of the human cyclo-oxygenase-2 gene. Biochem J 1994;302 (Pt 3):723-727.
13. Hla T, Neilson K. Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci USA 1992;89:7384-7388.
14. Saito S, Ibaraki T, Enomoto M, Ichijo M, Motoyoshi K. Macrophage colony-stimulating factor induces the growth and differentiation of normal pregnancy human cytotrophoblast cells and hydatidiform moles but does not induce the growth and differentiation of choriocarcinoma cells. Jpn J Cancer Res 1994;85:245-252.
15. Hunt JS, Soares MJ, Lei MG, Smith RN, Wheaton D, Atherton RA, Morrison DC. Products of lipopolysaccharide-activated macrophages (tumor necrosis factor-alpha, transforming growth factor-beta) but not lipopolysaccharide modify DNA synthesis by rat trophoblast cells exhibiting the 80-kDa lipopolysaccharide-binding protein. J Immunol 1989;143:1606-1613.
16. Kupferminc MJ, Peaceman AM, Wigton TR, Rehnberg KA, Socol ML. Tumor necrosis factor-alpha is elevated in plasma and amniotic fluid of patients with severe preeclampsia. Am J Obstet Gynecol 1994;170:1752-7; discussion 1757.
17. Conrad KP, Miles TM, Benyo DF. Circulating levels of immunoreactive cytokines in women with preeclampsia. Am J Reprod Immunol 1998;40:102-111.
18. Nasiell J, Nisell H, Blanck A, Lunell NO, Faxen M. Placental expression of endothelial constitutive nitric oxide synthase mRNA in pregnancy complicated by preeclampsia. Acta Obstet Gynecol Scand 1998;77:492-496.
19. Izumi H, Makino Y, Shirakawa K, Garfield RE. Role of nitric oxide on vasorelaxation in human umbilical artery. Am J Obstet Gynecol 1995;172:1477-1484.
20. Buhimschi I, Yallampalli C, Dong YL, Garfield RE. Involvement of a nitric oxide-cyclic guanosine monophosphate pathway in control of human uterine contractility during pregnancy. Am J Obstet Gynecol 1995;172:1577-1584.
21. Lyall F, Greer IA, Young A, Myatt L. Nitric oxide concentrations are increased in the feto-placental circulation in intrauterine growth restriction. Placenta 1996;17:165-168.
22. Lyall F, Young A, Greer IA. Nitric oxide concentrations are increased in the fetoplacental circulation in preeclampsia. Am J Obstet Gynecol 1995;173:714-718.
23. Purcell TL, Buhimschi IA, Given R, Chwalisz K, Garfield RE. Inducible nitric oxide synthase is present in the rat placenta at the fetalmaternal interface and decreases prior to labour. Mol Hum Reprod 1997;3:485-491.
24. Sun WH, Sun YL, Fang RN, Shao Y, Xu HC, Xue QP, Ding GX, Cheng YL. Expression of cyclooxygenase-2 and matrix metalloproteinase-9 in gastric carcinoma and its correlation with angiogenesis. Jpn J Clin Oncol 2005;35:707-713.
25. Tokyol C, Aktepe F, Dilek FH, Sahin O, Arioz DT. Expression of cyclooxygenase-2 and matrix metalloproteinase-2 in adenomyosis and endometrial polyps and its correlation with angiogenesis. Int J Gynecol Pathol 2009;28:148-156.
26. Robinson JS, Redman CW, Clover L, Mitchell MD. The concentrations of the prostaglandins E and F, 13 14-dihydro-15-oxo-prostaglandin F and thromboxane B2. In tissues obtained from women with and without pre-eclampsia. Prostaglandins Med 1979;3:223-234.
27. Johnson RD, Walsh SW, Everson WV, Nelson DM. Differentiation and growth on a fibrin matrix modulate the cyclooxygenase expression and thromboxane production by cultured human placental trophoblasts. Prostaglandins Leukot Essent Fatty Acids 1995;52:21-27.
28. Wetzka B, Nusing R, Charnock-Jones DS, Schafer W, Zahradnik HP, Smith SK. Cyclooxygenase-1 and -2 in human placenta and placental bed after normal and pre-eclamptic pregnancies. Hum Reprod 1997;12:2313-2320.
29. Khan I, al-Yatama M, Nandakumaran M. Expression of the Na(+)-H+ exchanger isoform-1 and cyclooxygenases in human placentas: Their implications in preeclampsia. Biochem Mol Biol Int 1999;47:715-722.
30. Borekci B, Aksoy H, Toker A, Ozkan A. Placental tissue cyclo-oxygenase 1 and 2 in pre-eclamptic and normal pregnancy. Int J Gynaecol Obstet 2006;95:127-131.
31. Beinder E, Mohaupt MG, Schlembach D, Fischer T, Sterzel RB, Lang N, Baylis C. Nitric oxide synthase activity and Doppler parameters in the fetoplacental and uteroplacental circulation in preeclampsia. Hypertens Pregnancy 1999;18:115-127.
32. Napolitano M, Miceli F, Calce A, Vacca A, Gulino A, Apa R, Lanzone A. Expression and relationship between endothelin-1 messenger ribonucleic acid (mRNA) and inducible/endothelial nitric oxide synthase mRNA isoforms from normal and preeclamptic placentas. J Clin Endocrinol Metab 2000;85:2318-2323.
33. Schiessl B, Mylonas I, Hantschmann P, Kuhn C, Schulze S, Kunze S, Friese K, Jeschke U. Expression of endothelial NO synthase, inducible NO synthase, and estrogen receptors alpha and beta in placental tissue of normal, preeclamptic, and intrauterine growth-restricted pregnancies. J Histochem Cytochem 2005;53:1441-1449.
34. Lyall F, Jablonka-Shariff A, Johnson RD, Olson LM, Nelson DM. Gene expression of nitric oxide synthase in cultured human term placental trophoblast during in vitro differentiation. Placenta 1998;19:253-260.
35. Myatt L, Eis AL, Brockman DE, Kossenjans W, Greer I, Lyall F. Inducible (type II) nitric oxide synthase in human placental villous tissue of normotensive, pre-eclamptic and intrauterine growth-restricted pregnancies. Placenta 1997;18:261-268.
36. Garvey EP, Tuttle JV, Covington K, Merrill BM, Wood ER, Baylis SA, Charles IG. Purification and characterization of the constitutive nitric oxide synthase from human placenta. Arch Biochem Biophys 1994;311:235-241.
37. Myatt L, Brewer AS, Langdon G, Brockman DE. Attenuation of the vasoconstrictor effects of thromboxane and endothelin by nitric oxide in the human fetal-placental circulation. Am J Obstet Gynecol 1992;166:224-230.
38. Myatt L, Brewer A, Brockman DE. The action of nitric oxide in the perfused human fetal-placental circulation. Am J Obstet Gynecol 1991;164:687-692.
39. Ramsay B, De Belder A, Campbell S, Moncada S, Martin JF. A nitric oxide donor improves uterine artery diastolic blood flow in normal early pregnancy and in women at high risk of pre-eclampsia. Eur J Clin Invest 1994;24:76-78.
40. Giles W, O'Callaghan S, Boura A, Walters W. Reduction in human fetal umbilical-placental vascular resistance by glyceryl trinitrate. Lancet 1992;340:856.
41. Szewczyk G, Szukiewicz D, Smiertka W, Szewczyk A. [Mast cells as a source of nitric oxide in the human placenta-morphometric analysis in preeclampsia complicated pregnancy]. Ginekol Pol 2005;76:720-726.
42. Sharma D, Singh A, Trivedi SS, Bhattacharjee J. Role of endothelin and inflammatory cytokines in pre-eclampsia -A pilot North Indian study. Am J Reprod Immunol 2011;65:428-432.
43. Tsukimori K, Komatsu H, Fukushima K, Kaku T, Nakano H, Wake N. Inhibition of nitric oxide synthetase at mid-gestation in rats is associated with increases in arterial pressure, serum tumor necrosis factor-alpha, and placental apoptosis. Am J Hypertens 2008;21:477-481.
44. Benyo DF, Smarason A, Redman CW, Sims C, Conrad KP. Expression of inflammatory cytokines in placentas from women with preeclampsia. J Clin Endocrinol Metab 2001;86:2505-2512.
45. Hayashi M, Ueda Y, Yamaguchi T, Sohma R, Shibazaki M, Ohkura T, Inaba N. Tumor necrosis factor-alpha in the placenta is not elevated in pre-eclamptic patients despite its elevation in peripheral blood. Am J Reprod Immunol 2005;53:113-119.
46. Pijnenborg R, McLaughlin PJ, Vercruysse L, Hanssens M, Johnson PM, Keith JC Jr, Van Assche FA. Immunolocalization of tumour necrosis factor-alpha (TNF-alpha) in the placental bed of normotensive and hypertensive human pregnancies. Placenta 1998;19:231-239.